Association of dual-pathway antithrombotic therapy with primary patency after iliofemoral venous stenting: a multicenter cohort study

Can Chen, Zhenyu Guo, Jian Tang, Zhiqing Wei, Guowei Liu, Zhenyu Shi, Daqiao Guo, Weiguo Fu, Qianzhou Lv, Baolei Guo · 2026

Read Association of dual-pathway antithrombotic therapy with primary patency after iliofemoral venous stenting: a multicenter cohort study by Can Chen, Zhenyu Guo, Jian Tang, Zhiqing Wei, Guowei Liu, Zhenyu Shi, Daqiao Guo, Weiguo Fu, Qianzhou Lv, Baolei Guo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13675916.txt.

Description

Can Chen and a large team of co-authors ask which blood-thinner strategy keeps leg vein stents open, in this 2026 study. After a stent is placed in the iliofemoral vein, doctors must choose between an anticoagulant alone or that drug plus an antiplatelet agent, the dual-pathway option. Practice varies because the best answer is unsettled.

The study followed two hundred forty-seven patients at several centers who received stents between 2019 and 2024. Overall, about ninety-one percent of stents stayed open, and the two strategies tied: patency did not differ between the groups. In the subgroup whose veins were scarred by past clots, though, the single-drug group lost patency more often than the dual group. The authors treat that signal as exploratory and call for a properly powered randomized trial with longer follow-up and safety checks.

Catalog record

CREATORCan Chen, Zhenyu Guo, Jian Tang, Zhiqing Wei, Guowei Liu, Zhenyu Shi, Daqiao Guo, Weiguo Fu, Qianzhou Lv, Baolei Guo
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE31 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13675916

Browse the full library · About the Tower of Babel